Overview Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. We are developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. We are advancing our late stage non-device based epinephrine prodrug product candidate for the treatment of severe allergic reactions, including anaphylax...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-04 | 2025-12-31 | 0001398733-26-000018 | EDGAR | 90K words |
| 2025-03-05 | 2024-12-31 | 0001628280-25-010506 | EDGAR | — |
| 2024-03-05 | 2023-12-31 | 0001628280-24-009010 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001628280-23-010180 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0001628280-22-005393 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001140361-21-007811 | EDGAR | — |
| 2020-03-11 | 2019-12-31 | 0001140361-20-005499 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001140361-19-004934 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001398733-26-000042 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001398733-25-000028 | EDGAR | 39K words |
| 2025-08-11 | 2025-06-30 | 0001398733-25-000013 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001628280-25-024664 | EDGAR | — |
| 2024-11-04 | 2024-09-30 | 0001628280-24-045030 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001628280-24-035225 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001628280-24-021118 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001628280-23-037100 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027818 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001628280-23-014920 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001628280-22-027580 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001628280-22-020244 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001398733-26-000041 | EDGAR | — |
| 2026-08-10 | 0001398733-26-000035 | EDGAR | — |
| 2026-03-30 | 0001398733-26-000022 | EDGAR | 1K words |
| 2026-03-20 | 0001398733-26-000020 | EDGAR | — |
| 2026-03-04 | 0001398733-26-000016 | EDGAR | — |
| 2026-02-26 | 0001398733-26-000007 | EDGAR | — |
| 2026-02-02 | 0001398733-26-000005 | EDGAR | — |
| 2026-01-09 | 0001398733-26-000003 | EDGAR | — |
| 2025-11-06 | 0001398733-25-000030 | EDGAR | — |
| 2025-11-05 | 0001398733-25-000027 | EDGAR | — |
240 total filings indexed. 210 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001398733 |
| Ticker | AQST |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aquestive.com |
| Listed | 2018-07-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AQST (~200 tokens, structured JSON with cryptographic provenance)